Sodium Chloride Injection, Solution, Concentrate
Product Images NDC 63323-099

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sodium Chloride (NDC 63323-099). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Sod1h 0000 01)

FDA Label Image

Figure (Sod1h 0000 02)

FDA Label Image

Package Label (PRINCIPAL DISPLAY – 23.4% Sodium Chloride Injection, USP Vial Label)

Label for Sodium Chloride Injection, USP concentrate, 23.4% strength (800 mEq/200 mL or 4 mEq/mL) in a 200 mL Maxvial preservative free solution. The label indicates the product is a pharmacy bulk package, not for direct infusion, from Fresenius Kabi USA, LLC, Lake Zurich, IL. Includes handling, storage, and usage cautions along with lot, expiration, date, and time entry fields.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – 23.4% Sodium Chloride Injection, USP Tray Label)

Label of Sodium Chloride Injection, USP concentrate solution at 23.4% strength (800 mEq/200 mL; 4 mEq/mL) by Fresenius Kabi USA, LLC. The label warns the product is a pharmacy bulk package for intravenous admixtures only, not for direct infusion, with storage and usage information. It includes barcode and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.